MAPT and Parkinson disease: Together, phosphorylation of tau protein mediates the pathological process of Alzheimer’s disease (AD) or PD, which is a potential therapeutic target treatment for neurodegenerative disease (Winer et al., 2018; Chen et al., 2019).